FAQ
Why are we doing this research?
People with psoriatic disease have told us that one of the worst parts about this disease is the uncertainty. There are looming questions about “When will this new therapy start working, and how long will it last?” or “Am I going to get psoriatic arthritis?” The Psorcast app is designed to understand psoriatic disease symptoms and how they change during the times between clinical visits. With a large open source data set, we aim to make, or help other scientists make, forecasts for outcomes like treatment effectiveness and development of arthritis. To find out more about the study, download the Psorcast app to explore and potentially join up as a participant.
Who is doing this research?
To accomplish the goals described above, the non-profit organizations Sage Bionetworks and PPACMAN (Psoriasis and Psoriatic Arthritis Clinics Multi-center Advancement Network) have partnered to create the pre-competitive Psorcast Consortium with industry partnership and funding from Novartis, UCB, Pfizer, and Janssen.
Study Team

Solly Sieberts, PhD
Sage Bionetworks

Jose Scher, MD
NYU Langone Medical Center

Joe Merola, MD, MMSc
Brigham and Women’s Hospital &
Harvard Medical School

Rebecca Haberman, MD, MSCI
NYU Langone Medical Center

Lourdes Perez Chada, MD, MMSc
Brigham and Women’s Hospital

Dan Webster, PhD
Sage Bionetworks (formerly)

Meghasyam Tummalacharla
Sage Bionetworks

Elias Chaibub Neto, PhD
Sage Bionetworks

Michael DePhillips
SDP Digital

Eric Sieg
SDP Digital

Stockard Simon
Sage Bionetworks

Vanessa Barone
Sage Bionetworks

Woody MacDuffie
Sage Bionetworks (formerly)

Aryton Tediarjo
Sage Bionetworks (formerly)

Vijay Yadav
Sage Bionetworks (formerly)
Psorcast Consortium Partners





